MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Free Cash flow
-$3,711K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Impairment loss
Accounts receivable
Stock-based compensation
Others
Negative Cash Flow Breakdown
Operating lease liabilities
Contract liabilities
Purchases of property and equipm...
Other noncurrent assets
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-43,393
-19,272
-20,175
-20,275
Depreciation and amortization
1,698
1,763
1,827
1,864
Amortization (accretion) of premium (discount) on marketable securities
0
0
0
111
Stock-based compensation
1,701
2,196
2,745
2,934
Non-cash operating lease expense
670
654
640
625
Impairment loss
21,821
-
-
-
Other
-1,140
-8
-130
-63
Accounts receivable
-10,256
10,627
-
-
Prepaid expenses and other current assets
-1,499
9
167
774
Other noncurrent assets
37
-461
2
-65
Accounts payable
988
-1,460
531
-447
Accrued and other current liabilities
1,584
-2,637
1,126
918
Contract liabilities
-739
10,402
-
-
Operating lease liabilities
-740
-713
-697
-683
Other noncurrent liabilities
-
-
102
-
Net cash used in operating activities
-3,552
-19,234
-13,940
-15,599
Purchases of property and equipment
159
11
67
26
Purchases of marketable securities
-
-
0
0
Proceeds from sales of marketable securities
0
0
0
10,958
Proceeds from maturities of marketable securities
0
0
0
8,886
Other
-
-
0
0
Net cash (used) provided by investing activities
-159
-11
-67
8,860
Proceeds from issuance of equity, net of issuance costs-Follow On Offering
0
0
56,264
0
Proceeds from exercise of stock options and employee stock purchase plan
43
-
45
24
Proceeds from exercise of warrants
866
-
1,933
356
Proceeds from exercises of pre-funded warrants
-
-
0
0
Proceeds from issuance of equity, net of issuance costs-At The Market Offering
0
0
0
0
Payment of accrued offering costs
0
415
-
-
Net cash provided by financing activities
909
-415
58,242
380
Net change in cash, cash equivalents and restricted cash
-2,802
-19,660
44,235
-6,359
Cash and cash equivalents and restricted cash at beginning of period
81,306
100,966
56,731
4,742
Cash and cash equivalents and restricted cash at end of period
78,504
81,306
100,966
56,731
Cash and cash equivalents
78,085
-
-
-
Restricted cash included in other noncurrent assets
419
-
-
-
Cash, cash equivalents and restricted cash
78,504
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
TNYA Cash Flow Sankey Diagram
Sankey diagram visualizing TNYA cash flow for the period
Proceeds from exercise of
warrants
$866K
Proceeds from exercise of
stock options and...
$43K
(-38.57%↓ Y/Y)
Net cash provided by
financing activities
$909K
(-98.17%↓ Y/Y)
Net change in cash,
cash equivalents and...
-$2,802K
(-104.80%↓ Y/Y)
Canceled cashflow
$909K
Impairment loss
$21,821K
Accounts receivable
-$10,256K
Stock-based compensation
$1,701K
(-76.91%↓ Y/Y)
Depreciation and
amortization
$1,698K
(-64.21%↓ Y/Y)
Accrued and other
current liabilities
$1,584K
(204.76%↑ Y/Y)
Prepaid expenses and
other current assets
-$1,499K
(-0.74%↓ Y/Y)
Other
-$1,140K
(-395.65%↓ Y/Y)
Accounts payable
$988K
(165.26%↑ Y/Y)
Non-cash operating lease
expense
$670K
(-44.54%↓ Y/Y)
Net cash used in
operating activities
-$3,552K
(90.83%↑ Y/Y)
Canceled cashflow
$41,357K
Net cash (used)
provided by investing...
-$159K
(-100.34%↓ Y/Y)
Net loss
-$43,393K
(13.47%↑ Y/Y)
Operating lease
liabilities
-$740K
(47.07%↑ Y/Y)
Contract liabilities
-$739K
Other noncurrent
assets
$37K
(107.28%↑ Y/Y)
Purchases of property and
equipment
$159K
(-69.71%↓ Y/Y)
Buy us a coffee
Tenaya Therapeutics, Inc. (TNYA)
Tenaya Therapeutics, Inc. (TNYA)